Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
IBM
IBM
|
+$328M |
| 2 |
Johnson & Johnson
JNJ
|
+$229M |
| 3 |
GE Aerospace
GE
|
+$156M |
| 4 |
Target
TGT
|
+$155M |
| 5 |
Walt Disney
DIS
|
+$153M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$283M |
| 2 |
Eli Lilly
LLY
|
+$211M |
| 3 |
Microsoft
MSFT
|
+$199M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$184M |
| 5 |
Citigroup
C
|
+$177M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.03% |
| 2 | Healthcare | 12.1% |
| 3 | Consumer Discretionary | 11.99% |
| 4 | Consumer Staples | 11.92% |
| 5 | Industrials | 10.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2626
Destination XL Group
DXLG
$33.2M
| $157K | ﹤0.01% |
+24,300
| New | +$156K |
|
2627
Opko Health
OPK
$1.04B
| $157K | ﹤0.01% |
+17,802
| New | +$143K |
|
|
FAC
2628
DELISTED
First Acceptance Corp.
FAC
| $156K | ﹤0.01% |
89,300
+9,900
| +12% | +$17.3K |
|
|
WG
2629
DELISTED
Willbros Group
WG
| $154K | ﹤0.01% |
16,800
-73,700
| -81% | -$619K |
|
|
PQUE
2630
DELISTED
PETROQUEST ENERGY INC (DE)
PQUE
| $153K | ﹤0.01% |
38,254
-80,400
| -68% | -$322K |
|
|
FST
2631
DELISTED
FOREST OIL CORPORATION
FST
| $152K | ﹤0.01% |
24,895
-3,116,300
| -99% | -$16.7M |
|
2632
CBAK Energy Technology Ltd
CBAT
$65.5M
| $151K | ﹤0.01% |
64,940
+30,700
| +90% | +$52K |
|
|
MICR
2633
DELISTED
Micron Solutions, Inc.
MICR
| $151K | ﹤0.01% |
56,100
| – | – |
|
2634
MakeMyTrip
MMYT
$5.71B
| $150K | ﹤0.01% |
+10,100
| New | +$139K |
|
|
ORKA
2635
Oruka Therapeutics
ORKA
$7.16B
| $150K | ﹤0.01% |
62
+52
| +520% | +$108K |
|
|
QCCO
2636
DELISTED
QC HLDGS INC
QCCO
| $149K | ﹤0.01% |
64,200
+4,000
| +7% | +$10.2K |
|
2637
Codexis
CDXS
$175M
| $148K | ﹤0.01% |
84,100
-74,800
| -47% | -$156K |
|
2638
Clear Channel Outdoor Holdings
CCO
$1.18B
| $147K | ﹤0.01% |
+17,900
| New | +$137K |
|
|
BSPM
2639
DELISTED
Biostar Pharmaceuticals, Inc.
BSPM
| $147K | ﹤0.01% |
28,053
+1,100
| +4% | +$6.03K |
|
|
NURO
2640
DELISTED
NeuroMetrix, Inc. Common Stock
NURO
| $145K | ﹤0.01% |
34
-2
| -6% | -$8.84K |
|
2641
Ultralife
ULBI
$124M
| $144K | ﹤0.01% |
36,000
-2,500
| -6% | -$9.42K |
|
2642
Cadiz
CDZI
$295M
| $143K | ﹤0.01% |
28,000
+5,700
| +26% | +$27.4K |
|
|
GUID
2643
DELISTED
Guidance Software, Inc.
GUID
| $141K | ﹤0.01% |
15,600
-25,800
| -62% | -$226K |
|
2644
Aehr Test Systems
AEHR
$4.02B
| $140K | ﹤0.01% |
59,000
+9,300
| +19% | +$15.7K |
|
|
ENG
2645
DELISTED
ENGlobal Corp
ENG
| $139K | ﹤0.01% |
17,863
+2,363
| +15% | +$20.6K |
|
|
AUD
2646
DELISTED
Audacy, Inc.
AUD
| $139K | ﹤0.01% |
+15,800
| New | +$147K |
|
|
PW
2647
Power REIT
PW
$2.93M
| $137K | ﹤0.01% |
1,610
-310
| -16% | -$26.1K |
|
|
KID
2648
DELISTED
KID BRANDS,INC COMMON STOCK
KID
| $137K | ﹤0.01% |
92,900
+1,700
| +2% | +$2.51K |
|
|
TECUB
2649
DELISTED
TECUMSEH PRODUCTS CO CL-B
TECUB
| $136K | ﹤0.01% |
15,700
+3,800
| +32% | +$32.9K |
|
|
BLRX
2650
BioLineRX
BLRX
$11.8M
| $135K | ﹤0.01% |
103
+53
| +106% | +$62.6K |
|
Similar funds
Jim Simons's Q3 2013 Portfolio in Review
As of Q3 2013, Jim Simons held 3,196 positions worth $41.2B, up 8.1% from $38.1B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons's Q3 2013 filing shows 439 new, 1,284 increased, 1,031 reduced and 412 closed positions. Its largest new stake was GE Aerospace: 1,361,721 shares worth $156M. The largest sale was Apple, an estimated $283M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q3 2013 buy was GE Aerospace: 1,361,721 shares worth $156M.
- Jim Simons added most to IBM in Q3 2013, an estimated $328M increase.
- Jim Simons's biggest Q3 2013 reduction was Eli Lilly, cutting an estimated $211M.
- Jim Simons fully exited Apple in Q3 2013, selling an estimated $283M.
- Jim Simons's ten largest holdings make up 11% of its $41.2B portfolio in Q3 2013.
- Jim Simons opened 439 new positions and closed 412 in Q3 2013.
- Jim Simons's portfolio value rose 8.1% quarter-over-quarter to $41.2B.
Based on Renaissance Technologies's 13F filing for Q3 2013, filed 13 Nov 2013.